(Q35108019)

6 August 2017

1 reference

title

Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors (English)

1 reference

6 August 2017

Advances in the Diagnosis, Molecular Genetics, and Treatment of Pediatric Embryonal CNS Tumors (English)

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

24 December 2023

1 reference

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

24 December 2023

author name string

Gilbert Vezina

4

1 reference

6 August 2017

Kimberly Bingaman

5

1 reference

6 August 2017

Tobey J. MacDonald

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697942

24 December 2023

Brian R. Rood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697942

24 December 2023

Maria R. Santi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697942

24 December 2023

Philip H. Cogen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697942

24 December 2023

Roger J. Packer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697942

24 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12697942

24 December 2023

publication date

1 January 2003

1 reference

full work available at URL

6 August 2017

https://academic.oup.com/oncolo/article-pdf/8/2/174/41840501/oncolo_8_2_174.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697942

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.8-2-174

24 December 2023

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

https://onlinelibrary.wiley.com/doi/full-xml/10.1634/theoncologist.8-2-174

24 December 2023

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

https://academic.oup.com/oncolo/article-pdf/8/2/174/41840501/oncolo_8_2_174.pdf

24 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

24 December 2023

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

174-186

1 reference

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

6 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/28212

Prediction of central nervous system embryonal tumour outcome based on gene expression

3

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

24 December 2023

4

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Cerebellar “neuroblastoma”: Nosology as it relates to medulloblastoma

24 December 2023

6

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Primitive neuroectodermal tumors of the brain in children

24 December 2023

7

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma

24 December 2023

9

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas

24 December 2023

10

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors

24 December 2023

11

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma

24 December 2023

12

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Cytogenetics and molecular genetics of childhood brain tumors

24 December 2023

19

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.

24 December 2023

20

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system

24 December 2023

21

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

24 December 2023

23

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Medulloblastoma: clinical and biologic aspects

24 December 2023

24

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Uncommon presentation of medulloblastoma

24 December 2023

25

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Diffusion-weighted imaging and fluid attenuated inversion recovery imaging in the evaluation of primitive neuroectodermal tumors

24 December 2023

26

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

MR findings on primitive neuroectodermal tumors

24 December 2023

27

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Medulloblastoma: staging and treatment outcome.

24 December 2023

28

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.

24 December 2023

29

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors

24 December 2023

30

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group

24 December 2023

31

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

24 December 2023

32

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Management of hydrocephalus in children with medulloblastoma: prognostic factors for shunting.

24 December 2023

33

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology

24 December 2023

34

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

The surgical and natural morbidity of aggressive resection for posterior fossa tumors in childhood.

24 December 2023

35

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Tumour type and size are high risk factors for the syndrome of "cerebellar" mutism and subsequent dysarthria

24 December 2023

36

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided

24 December 2023

37

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

24 December 2023

38

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study

24 December 2023

39

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

24 December 2023

40

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity

24 December 2023

42

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Monosomy 22 in rhabdoid or atypical tumors of the brain

24 December 2023

43

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study

24 December 2023

44

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Successful treatment of disseminated central nervous system malignant rhabdoid tumor

24 December 2023

45

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Malignant rhabdoid tumor of brain: an aggressive clinical entity.

24 December 2023

46

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature

24 December 2023

47

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Clinicopathological characteristics of atypical teratoid/rhabdoid tumor

24 December 2023

48

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma

24 December 2023

49

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood

24 December 2023

50

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors

24 December 2023

52

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5

24 December 2023

53

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations

24 December 2023

54

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers

24 December 2023

55

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop

24 December 2023

56

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study

24 December 2023

57

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors

24 December 2023

58

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination

24 December 2023

59

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.

24 December 2023

60

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration

24 December 2023

61

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

24 December 2023

62

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity

24 December 2023

63

1 reference

https://api.crossref.org/works/10.1634/THEONCOLOGIST.8-2-174

24 December 2023

Identifiers

1 reference

6 August 2017

1 reference